Cheng‐Chang Chang

ORCID: 0000-0002-7356-446X · 12 papers in corpus
2022
Cancers ·doi:10.3390/cancers14071651

Ovarian cancer is a common malignant gynecological disease. Molecular target therapy, i.e., antiangiogenesis with bevacizumab, was found to be effective in some patients of epithelial ovarian cancer (EOC). Although careful patient selection…

2021
Journal of clinical medicine ·doi:10.3390/jcm10194529

Antiangiogenic therapy, such as bevacizumab (BEV), has improved progression-free survival (PFS) and overall survival (OS) in high-risk patients with epithelial ovarian cancer (EOC) according to several clinical trials. Clinically, no reliab…

article 2020
·doi:10.1016/j.ygyno.2020.05.230
other 2020
International journal of molecular sciences ·doi:10.3390/ijms21082824

Ovarian clear cell carcinoma (OCCC) is the second most common epithelial ovarian carcinoma (EOC). It is refractory to chemotherapy with a worse prognosis after the preliminary optimal debulking operation, such that the treatment of OCCC rem…

review 2020
Journal of the Chinese Medical Association : JCMA ·doi:10.1097/jcma.0000000000000262

Endometriosis-associated ovarian cancers (EAOCs) including endometrioid and clear cell ovarian carcinoma are subgroups of epithelial ovarian carcinomas (EOCs), which is generally acknowledged as the most lethal gynecological malignancy. End…

2020
International journal of environmental research and public health ·doi:10.3390/ijerph17165993

Myometrial invasion affects the prognosis of endometrial cancer. However, discrepancies exist between pre-operative magnetic resonance imaging staging and post-operative pathological staging. This study aims to validate the accuracy of arti…

2018
International journal of molecular sciences ·doi:10.3390/ijms19113311

Serous carcinoma (SC) is the most common and lethal subtype of epithelial ovarian carcinoma; immunotherapy is a potential treatment for SC, however, the global immunological functions of SC as well as their change during the progression of …

2018
Journal of gynecologic oncology ·doi:10.3802/jgo.2018.29.e17

ObjectiveWe hypothesized that DNA methylation of development-related genes may occur in endometrial cancer (EC)/ovarian cancer (OC) and may be detected in cervical scrapings.MethodsWe tested methylation status by quantitative methylation-sp…

article 2017
Oncotarget ·doi:10.18632/oncotarget.23364

The coexistence of endometriosis (ES) with ovarian clear cell carcinoma (CCC) or endometrioid carcinoma (EC) suggested that malignant transformation of ES leads to endometriosis associated ovarian carcinoma (EAOC). However, there is still l…

letter 2015
Taiwanese Journal of Obstetrics and Gynecology ·doi:10.1016/j.tjog.2015.10.022
other 2012
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2012.01.005

OBJECTIVE: Minimally invasive surgery has been the trend in various specialties and continues to evolve as new technology develops. The development of robotic surgery in gynecology remains in its infancy. The present study reports the first…

article 2004